By PPN News Staff
The FDA has approved the use of ustekinumab (Stelara, Janssen) for the treatment of moderate to severe ulcerative colitis in adults.
Ustekinumab was previously approved for a variety of rheumatologic conditions and for the treatment of moderate to severe Crohn’s disease in adults. Approval for the expanded indication was based on findings from the phase 3 UNIFI trial, which showed that the drug was more effective than placebo at inducing and maintaining clinical remission,